BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17438955)

  • 1. [Current progress on cellular oxygen sensors: the family of hypoxia inducible factor-1 prolyl hydroxylase].
    Li PY; Zhang CG
    Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):62-5. PubMed ID: 17438955
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on "Hypoxia, hypoxic signaling, tissue damage, and detection of reactive oxygen species (ROS)".
    White CW
    Free Radic Biol Med; 2006 Mar; 40(6):923-7. PubMed ID: 16540387
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases.
    Hirota K; Semenza GL
    Biochem Biophys Res Commun; 2005 Dec; 338(1):610-6. PubMed ID: 16154531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease.
    Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):43-50. PubMed ID: 19779337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets.
    Myllyharju J
    Ann Med; 2008; 40(6):402-17. PubMed ID: 19160570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor.
    Bruick RK
    Genes Dev; 2003 Nov; 17(21):2614-23. PubMed ID: 14597660
    [No Abstract]   [Full Text] [Related]  

  • 7. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha.
    Willam C; Nicholls LG; Ratcliffe PJ; Pugh CW; Maxwell PH
    Adv Enzyme Regul; 2004; 44():75-92. PubMed ID: 15581484
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H; Sridharan V; Wright G
    Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
    Erez N; Milyavsky M; Eilam R; Shats I; Goldfinger N; Rotter V
    Cancer Res; 2003 Dec; 63(24):8777-83. PubMed ID: 14695194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity.
    Cervera AM; Apostolova N; Luna-Crespo F; Sanjuan-Pla A; Garcia-Bou R; McCreath KJ
    Cancer Lett; 2006 Feb; 233(1):131-8. PubMed ID: 16473674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
    Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
    Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential.
    Lee K A; Lynd JD; O'Reilly S; Kiupel M; McCormick JJ; LaPres JJ
    Mol Cancer Res; 2008 May; 6(5):829-42. PubMed ID: 18505927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis.
    Percy MJ; Zhao Q; Flores A; Harrison C; Lappin TR; Maxwell PH; McMullin MF; Lee FS
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):654-9. PubMed ID: 16407130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron homeostasis and its interaction with prolyl hydroxylases.
    Mole DR
    Antioxid Redox Signal; 2010 Apr; 12(4):445-58. PubMed ID: 19650690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).
    Ozer A; Wu LC; Bruick RK
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7481-6. PubMed ID: 15897452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression.
    Stockmann C; Fandrey J
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):968-79. PubMed ID: 17002676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy.
    Prabhu V; Guruvayoorappan C
    Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):568-75. PubMed ID: 21226555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.